Literature DB >> 29406563

Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.

G A Yanus1,2, T A Akhapkina1,2, A O Ivantsov1,2, E V Preobrazhenskaya1,2, S N Aleksakhina1, I V Bizin3, A P Sokolenko1,2, N V Mitiushkina1, E Sh Kuligina1, E N Suspitsin1,2, A R Venina1, M M Holmatov1,2, O A Zaitseva1, O S Yatsuk1, D V Pashkov4, A M Belyaev1,4, A V Togo1, E N Imyanitov1,2,5,6, A G Iyevleva1,2.   

Abstract

Distribution of cancer-predisposing mutations demonstrates significant interethnic variations. This study aimed to evaluate patterns of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies. APC gene defects were identified in 26/38 (68%) subjects with colon polyposis; 8/26 (31%) APC mutations were associated with 2 known mutational hotspots (p.E1309Dfs*4 [n = 5] and p.Q1062fs* [n = 3]), while 6/26 (23%) mutations were novel (p.K73Nfs*6, p.S254Hfs*12, p.S1072Kfs*9, p.E1547Kfs*11, p.L1564X and p.C1263Wfs*22). Biallelic mutations in MUTYH gene were detected in 3/12 (25%) remaining subjects with polyposis and in 6/90 (6.7%) patients with colorectal cancer (CRC) carrying KRAS p.G12C substitution, but not in 231 early-onset CRC cases negative for KRAS p.G12C allele. In addition to known European founder alleles p.Y179C and p.G396D, this study revealed a recurrent character of MUTYH p.R245H germ-line mutation. Besides that, 3 novel pathogenic MUTYH alleles (p.L111P, p.R245S and p.Q293X) were found. Targeted next-generation sequencing of 7 APC/MUTYH mutation-negative DNA samples identified novel potentially pathogenic POLD1 variant (p.L460R) in 1 patient and known low-penetrant cancer-associated allele CHEK2 p.I157T in 3 patients. The analysis of 1120 healthy subjects revealed 15 heterozygous carriers of recurrent MUTYH mutations, thus the expected incidence of MUTYH-associated polyposis in Russia is likely to be 1:23 000.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  APC; CHEK2; MUTYH; MUTYH-associated polyposis (MAP); POLD1; colorectal neoplasms; familial adenomatous polyposis (FAP)

Mesh:

Substances:

Year:  2018        PMID: 29406563     DOI: 10.1111/cge.13228

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  MUTYH-associated tumor syndrome: The other face of MAP.

Authors:  Luigi Magrin; Daniele Fanale; Chiara Brando; Lidia Rita Corsini; Ugo Randazzo; Marianna Di Piazza; Vittorio Gurrera; Erika Pedone; Tancredi Didier Bazan Russo; Salvatore Vieni; Gianni Pantuso; Antonio Russo; Viviana Bazan
Journal:  Oncogene       Date:  2022-04-14       Impact factor: 9.867

Review 2.  Molecular Diagnostics in Clinical Oncology.

Authors:  Anna P Sokolenko; Evgeny N Imyanitov
Journal:  Front Mol Biosci       Date:  2018-08-27

Review 3.  Advances in Identification of Susceptibility Gene Defects of Hereditary Colorectal Cancer.

Authors:  Qiang Liu; Yue-Qiu Tan
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

4.  Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.

Authors:  Dan Wang; Shengyun Liang; Xipeng Zhang; Subrata Kumar Dey; Yuwei Li; Chen Xu; Yongjun Yu; Mingsen Li; Guoru Zhao; Zhao Zhang
Journal:  Mol Genet Genomic Med       Date:  2018-12-06       Impact factor: 2.183

Review 5.  Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives.

Authors:  Svetlana N Aleksakhina; Evgeny N Imyanitov
Journal:  Int J Mol Sci       Date:  2021-10-10       Impact factor: 5.923

Review 6.  Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.

Authors:  Jernej Gašperšič; Alja Videtič Paska
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.